Last reviewed · How we verify
Chlamydial pelvic inflammatory disease
Approved treatments
- ALATROFLOXACIN · Pfizer
- Zithromax · Pfizer Inc.
Macrolide antibiotic that binds the 50S ribosomal subunit, inhibiting bacterial protein synthesis with an exceptionally long tissue half-life. - Noroxin
- Floxin
- Ofloxacine · Assistance Publique - Hôpitaux de Paris
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Chlamydial pelvic inflammatory disease patent landscape — cliff calendar, originator estates, attackable patents
- Chlamydial pelvic inflammatory disease treatment landscape brief
- Chlamydial pelvic inflammatory disease treatment updates RSS
Frequently asked questions about Chlamydial pelvic inflammatory disease
What drugs treat Chlamydial pelvic inflammatory disease?
Tracked treatments include ALATROFLOXACIN, Zithromax, Noroxin, Floxin, Ofloxacine.
What is the treatment for Chlamydial pelvic inflammatory disease?
Standard treatment for Chlamydial pelvic inflammatory disease includes ALATROFLOXACIN, Zithromax, Noroxin, Floxin, Ofloxacine. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Chlamydial pelvic inflammatory disease patent cliff · Chlamydial pelvic inflammatory disease CI report
- Treatment: ALATROFLOXACIN · Pfizer
- Treatment: Zithromax · Pfizer Inc.
- Treatment: Noroxin
- Treatment: Floxin
- Treatment: Ofloxacine · Assistance Publique - Hôpitaux de Paris
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing